Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian G Hartinger

Showing results (141-150 of 190) with videos related to

Pageof 19
Sort By:
Journal of Inorganic Biochemistry|July 30, 2019
Hydroxyquinoline-derived anticancer organometallics: Introduction of amphiphilic PTA as an ancillary ligand increases their aqueous solubilityWilliam D J Tremlett, Kelvin K H Tong, Tasha R Steel, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|January 24, 2013
Am(m)ines make the difference: organoruthenium am(m)ine complexes and their chemistry in anticancer drug developmentMaria V Babak, Samuel M Meier, Anton A Legin, et al.
Anti-Cancer Drugs|February 12, 2009
Pharmacokinetics of a novel anticancer ruthenium complex (KP1019, FFC14A) in a phase I dose-escalation studyFrederike Lentz, Anne Drescher, Andreas Lindauer, et al.
Molecular Pharmacology|October 20, 2006
Reversion of structure-activity relationships of antitumor platinum complexes by acetoxime but not hydroxylamine ligandsStefanie Zorbas-Seifried, Michael A Jakupec, Nikolay V Kukushkin, et al.
Chemical Communications (Cambridge, England)|March 19, 2013
Organometallic anticancer complexes of lapachol: metal centre-dependent formation of reactive oxygen species and correlation with cytotoxicityWolfgang Kandioller, Evelyn Balsano, Samuel M Meier, et al.
Dalton Transactions (Cambridge, England : 2003)|May 24, 2016
Towards targeting anticancer drugs: ruthenium(ii)-arene complexes with biologically active naphthoquinone-derived ligand systemsMario Kubanik, Wolfgang Kandioller, Kunwoo Kim, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|March 25, 2025
The Chemistry of Anticancer Mononuclear and N-Bridged Dinuclear 8-Aminoquinoline Half-sandwich Metal ComplexesTasha R Steel, Julia Stjärnhage, Mie Riisom, et al.
Dalton Transactions (Cambridge, England : 2003)|November 17, 2021
Impact of the ferrocenyl group on cytotoxicity and KSP inhibitory activity of ferrocenyl monastrol conjugatesAnna Wieczorek-Błauż, Karolina Kowalczyk, Andrzej Błauż, et al.
Journal of Inorganic Biochemistry|February 22, 2014
Antitumor pentamethylcyclopentadienyl rhodium complexes of maltol and allomaltol: synthesis, solution speciation and bioactivityOrsolya Dömötör, Sabine Aicher, Melanie Schmidlehner, et al.
Electrophoresis|July 9, 2004
Platinum metallodrug-protein binding studies by capillary electrophoresis-inductively coupled plasma-mass spectrometry: characterization of interactions between Pt(II) complexes and human serum albuminAndrei R Timerbaev, Svetlana S Aleksenko, Kasia Polec-Pawlak, et al.
Pageof 19

Showing results (141-150 of 190) with videos related to

Sort By:
Pageof 19
Journal of Inorganic Biochemistry|July 30, 2019
Hydroxyquinoline-derived anticancer organometallics: Introduction of amphiphilic PTA as an ancillary ligand increases their aqueous solubilityWilliam D J Tremlett, Kelvin K H Tong, Tasha R Steel, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|January 24, 2013
Am(m)ines make the difference: organoruthenium am(m)ine complexes and their chemistry in anticancer drug developmentMaria V Babak, Samuel M Meier, Anton A Legin, et al.
Anti-Cancer Drugs|February 12, 2009
Pharmacokinetics of a novel anticancer ruthenium complex (KP1019, FFC14A) in a phase I dose-escalation studyFrederike Lentz, Anne Drescher, Andreas Lindauer, et al.
Molecular Pharmacology|October 20, 2006
Reversion of structure-activity relationships of antitumor platinum complexes by acetoxime but not hydroxylamine ligandsStefanie Zorbas-Seifried, Michael A Jakupec, Nikolay V Kukushkin, et al.
Chemical Communications (Cambridge, England)|March 19, 2013
Organometallic anticancer complexes of lapachol: metal centre-dependent formation of reactive oxygen species and correlation with cytotoxicityWolfgang Kandioller, Evelyn Balsano, Samuel M Meier, et al.
Dalton Transactions (Cambridge, England : 2003)|May 24, 2016
Towards targeting anticancer drugs: ruthenium(ii)-arene complexes with biologically active naphthoquinone-derived ligand systemsMario Kubanik, Wolfgang Kandioller, Kunwoo Kim, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|March 25, 2025
The Chemistry of Anticancer Mononuclear and N-Bridged Dinuclear 8-Aminoquinoline Half-sandwich Metal ComplexesTasha R Steel, Julia Stjärnhage, Mie Riisom, et al.
Dalton Transactions (Cambridge, England : 2003)|November 17, 2021
Impact of the ferrocenyl group on cytotoxicity and KSP inhibitory activity of ferrocenyl monastrol conjugatesAnna Wieczorek-Błauż, Karolina Kowalczyk, Andrzej Błauż, et al.
Journal of Inorganic Biochemistry|February 22, 2014
Antitumor pentamethylcyclopentadienyl rhodium complexes of maltol and allomaltol: synthesis, solution speciation and bioactivityOrsolya Dömötör, Sabine Aicher, Melanie Schmidlehner, et al.
Electrophoresis|July 9, 2004
Platinum metallodrug-protein binding studies by capillary electrophoresis-inductively coupled plasma-mass spectrometry: characterization of interactions between Pt(II) complexes and human serum albuminAndrei R Timerbaev, Svetlana S Aleksenko, Kasia Polec-Pawlak, et al.
Pageof 19